Karolinska Development’s portfolio company Dilafor advances tafoxiparin following successful meetings with FDA and European regulatory authorities
KDEV) today announces that its portfolio company Dilafor has successfully completed regulatory meetings with the U.S. Food and Drug Administration, FDA, and European Health Agencies, regarding the ...
securingindustry.com1h
Europol issues warning over online drug purchases
A crackdown on the sale of counterfeit medicines online, coordinated by Europol, has resulted in the seizure of items worth ...